Meningiomas in Singapore: Demographic and biological characteristics

Journal of Neuro-Oncology

Volumn 47, Issue 2, 2000, Pages 153-160

  Das, A ^a   Tang, W Y ^a   Smith, D R ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Apoptosis; Bax; Immunohistochemistry; Incidence; p53; Tumour

Indexed keywords

PROTEIN BAX; PROTEIN P53;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; ASIAN; CANCER INCIDENCE; CARCINOGENESIS; CHILD; CHINESE; DEMOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; MENINGIOMA; NICK END LABELING; SINGAPORE; TUMOR NECROSIS;

APOPTOSIS; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RANDOM ALLOCATION; SINGAPORE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033843476     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006484829159     Document Type: Article

References (35)

1. Meningiomas
2. Meningiomas
3. Intrakranielle Tumouren
4. Meningiomas
5. Etiology and biology of meningiomas
6. Current management of meningiomas
7. Epidemiology and etiology of intracranial tumours: A review
8. Statistical analysis of central nervous system tumours in China
9. Comparative study of brain tumours treated at China Medical University, China and Kyushu University, Japan
10. Pathology of meningiomas
11. Malignant meningioma: A clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry
12. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
13. Accumulation of wild-type p53 in meningiomas
14. Prognostic significance of MIB-1, p53, and bcl-2 immunore-activity in meningiomas
15. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system
16. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas
17. Detection of TP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffinembedded samples
18. The yin and yang of p53 in cellular proliferation
19. Relationship of p53 to the control of apoptotic cell death
20. Proliferation and DNA fragmentation in meningioma subtypes
21. A study of apoptosis in brain tumours by in situ end-labeling method
22. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors
23. Alteration of bcl-2 and bax expression in embolized meningiomas
24. Apoptosis is associated with atypical or malignant change in meningiomas: An in situ labelling and immunohistochemical study
25. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques
26. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
27. Statistical Release 1: Demographic Characteristics
28. Movement of Bax from the cytosol to mitochondria during apoptosis
29. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate amongst apoptosis, necrosis, and autolytic cell death: A cautionary note
30. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas
31. Regulation of Mdm2-directed degradation by the C terminus of p53
32. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status
33. Regulation of p53 downstream genes
34. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
35. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene